Meibomian gland dysfunction in patients with thyroid-associated ophthalmopathy: a systematic review and meta-analysis. [PDF]
Lu Y, Li Y, Lin T.
europepmc +1 more source
Quantitative intravoxel incoherent motion diffusion-weighted imaging histogram profiling identifies diffusion biomarkers for active thyroid-associated ophthalmopathy. [PDF]
Li D, Zhang N, Wang Y, Zhu T.
europepmc +1 more source
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy. [PDF]
Song Y +6 more
europepmc +1 more source
Choroidal profile in patients with inactive thyroid-associated ophthalmopathy. [PDF]
Samadi M +7 more
europepmc +1 more source
Optimal timing for cataract surgery in patients with thyroid-associated ophthalmopathy. [PDF]
Miao N, Chen YC, He WM.
europepmc +1 more source
Gypenosides attenuate H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway. [PDF]
Ma C +6 more
europepmc +1 more source
A novel nomogram based on orbital MRI parameters for early prediction of dysthyroid optic neuropathy in thyroid-associated ophthalmopathy. [PDF]
Zhao X, Li Y, Lu Y, Liu M, Li Z.
europepmc +1 more source
Cerium oxide nanoparticles attenuates fibrosis and inflammation in thyroid-associated ophthalmopathy via JNK pathway. [PDF]
Wang BW +5 more
europepmc +1 more source
Investigation of the molecular mechanism of Xiaoluo Wan in thyroid-associated ophthalmopathy: network analysis and in vivo study. [PDF]
Gu W +5 more
europepmc +1 more source
Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid-Associated Ophthalmopathy. [PDF]
Li D, Zhu T, Wang Y.
europepmc +1 more source

